Please try another search
For the three months ended 31 March 2019, Brasil Pharma SA revenues decreased 39% to R$1.6M. Net loss before extraordinary items decreased 84% to R$24.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Equity Earnings decrease of 90% to R$11.9M (expense), Financial Expenses Remaining increase from R$14.7M (expense) to R$173K (income).
Period Ending: | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Total Revenue | 1.64 | 2.28 | 2.33 | 2.21 |
Gross Profit | 1.6 | 2.24 | 2.3 | 2.16 |
Operating Income | -18.01 | -7.14 | -5.33 | -5.97 |
Net Income | -23.91 | 1282.3 | -12.37 | -69.53 |
Period Ending: | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Total Assets | 70.49 | 72.15 | 78.92 | 89.74 |
Total Liabilities | 362.78 | 340.53 | 1629.6 | 1628.05 |
Total Equity | -292.29 | -268.38 | -1550.68 | -1538.31 |
Period Ending: | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -14.26 | -86.12 | -74.07 | -53.67 |
Cash From Investing Activities | 0 | -0.62 | -0.62 | -0.62 |
Cash From Financing Activities | 13.92 | 84.53 | 77.05 | 55.57 |
Net Change in Cash | -0.34 | -2.21 | 2.36 | 1.28 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review